- Shadow Work: How Businesses Are Turning Us All Into Unpaid Laborers
- IsoRay Takes Liberties With Lung Cancer Study Results to Prop Up Stock Price
- Carnival CEO Aims to Bust the Biggest Myths About the Cruise Industry
- Boomers' Biggest Retirement Regret? They Didn't Work Longer
- The 10 Poorest States in America
We added two new positions to the portfolio this week as the S&P 500 moved slightly higher.
Snap judgments on certain stocks can cost you.
TheStreet's Jim Cramer says the American farm is in dire straits, and that doesn't bode well for Deere, which reports earnings Friday. Meanwhile, Campbell needs more organic foods.
Jim Cramer explains recent moves in the charitable-trust portfolio.
We'll take some gains in Kinder and Schlumberger and direct them to these more attractively valued holdings.
Jim Cramer answers viewers' Twitter questions from the floor of the New York Stock Exchange.
We're sticking with it, though we're a little queasy.
This morning, Jim Cramer is hearing more thought-provoking rumors than he has in ages. So what else can he do but pass along the reasons why some stocks are running?
We're selling 950 shares of Merck to buy 300 of Express Scripts.
Investor meeting strengthens our confidence in its ability to meet financial goals.